
Geritam 0.2mg Tablet MR
Marketer
Septalyst Lifesciences Pvt.Ltd.
Salt Composition
Tamsulosin (0.2mg)
Overview Geritam 0.2mg Tablet MR
Alfuzosin 0.2mg modified-release tablets are alpha-1 blockers indicated for managing benign prostatic hyperplasia (BPH). This medication alleviates urinary symptoms such as hesitancy, but doesn't reduce prostate volume. Always adhere to your physician's prescribed dosage and regimen. It can be taken with or without food, but consistency in timing is crucial. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms, so complete the prescribed course. This medication may cause common side effects including lightheadedness, back discomfort, chest pain, impaired ejaculation, and retrograde ejaculation. Report any persistent or bothersome side effects promptly to your doctor. Simple lifestyle adjustments can improve symptom control. Void when you feel the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeine and alcohol. Before starting treatment, disclose all other medications and health conditions to your doctor. If cataract or glaucoma surgery is planned, inform your ophthalmologist about alfuzosin use. Patients with liver impairment require close monitoring and regular check-ups as directed by their doctor.
Uses of Geritam 0.2mg Tablet MR
Managing benign prostatic enlargement
Major Benefits of Geritam 0.2mg Tablet MR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Geritam 0.2mg Modified-Release Tablet can be consumed with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Geritam 0.2mg Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Geritam 0.2mg Tablet MR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Geritam 0.2mg Tablet MR can be consumed with or without food, although consistent timing is recommended.
How Geritam 0.2mg Tablet MR works:
Geritam 0.2mg Modified-Release Tablets are alpha-adrenergic receptor antagonists. Their mechanism of action involves relaxing the bladder neck and prostate muscles, facilitating smoother urine flow. This improves bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Geritam 0.2mg modified-release tablets and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Geritam 0.2mg modified-release tablets in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Geritam 0.2mg Tablet MR while breastfeeding is likely unsafe. Available data suggests potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated for lactating women.
DrivingSAFE
Driving ability is typically unaffected by Geritam 0.2mg MR tablets.
KidneySAFE IF PRESCRIBED
Geritam 0.2mg MR tablets are considered safe for patients with kidney impairment; no dosage modification is typically necessary. Nevertheless, data regarding its use in individuals with end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Geritam 0.2mg Tablet MR. Dosage modification of Geritam 0.2mg Tablet MR may be necessary. Physician consultation is advised.
What if you forget to take Geritam 0.2mg Tablet MR :
Should you forget a Geritam 0.2mg Tablet MR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Geritam 0.2mg Tablet MR
| Label | Value |
|---|---|
| Chemical Type | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
